Evidence of recombination in intrapatient populations of hepatitis C virus

PLoS ONE

Volumn 3, Issue 9, 2008, Pages

  Sentandreu, Vicente ^a   Jiménez Hernández, Nuria ^a,b   Torres Puente, Manuela ^a   Bracho, María Alma ^a,b   Valero, Ana ^a   Gosalbes, María José ^a,b   Ortega, Enrique ^c   Moya, Andrés ^a,b   González Candelas, Fernando ^a,b  

^a UNIVERSITY OF VALENCIA   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIRETROVIRUS AGENT; GLYCOPROTEIN E1; GLYCOPROTEIN E2; NONSTRUCTURAL PROTEIN 5A; RIBAVIRIN; ANTIVIRUS AGENT;

ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; DRUG RESPONSE; GENE AMPLIFICATION; GENE SEQUENCE; GENETIC VARIABILITY; HEPATITIS C; HEPATITIS C VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MIXED INFECTION; MOLECULAR PHYLOGENY; NONHUMAN; NUCLEOTIDE SEQUENCE; RETROSPECTIVE STUDY; VIRUS GENOME; VIRUS RECOMBINATION; ALGORITHM; BIOLOGICAL MODEL; GENETIC RECOMBINATION; GENOME; GENOTYPE; METABOLISM; PHYLOGENY; STATISTICAL MODEL;

FLAVIVIRIDAE; HEPATITIS C VIRUS; RNA VIRUSES;

ALGORITHMS; ANTIVIRAL AGENTS; GENETIC VARIATION; GENOME; GENOTYPE; HEPACIVIRUS; LIKELIHOOD FUNCTIONS; MODELS, GENETIC; PHYLOGENY; RECOMBINATION, GENETIC; SOFTWARE;

EID: 52449096112     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0003239     Document Type: Article

References (103)

1. Shepard CW, Finelli L, Alter MJ (2005) Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 5: 558-567.
2. Simmonds P (2004) Genetic diversity and evolution of hepatitis C virus - 15 years on. J Gen Virol 85: 3173-3188.
3. Schulze zur Wiesch J, Schmitz H, Borowski E, Borowski P (2003) The proteins of the Hepatitis C virus: Their features and interactions with intracellular protein phosphorylation. Arch Virol 148: 1247-1267.
4. Simmonds P, Holmes EC, Cha TA, Chan SW, McOmish F, et al. (1993) Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 74(Pt 11): 2391-2399.
5. Simmonds P, Bukh J, Combet C, Deleage G, Enomoto N, et al. (2005) Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42: 962-973.
6. Hadziyannis SJ, Sette H Jr, Morgan TR, Balan V, Diago M, et al. (2004) Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Ann Intern Med 140: 346-355.
7. Hnatyszyn HJ (2005) Chronic hepatitis C and genotyping: the clinical significance of determining HCV genotypes. Antiviral Therapy 10: 1-11.
8. Pybus OG, Cochrane A, Holmes EC, Simmonds P (2005) The hepatitis C virus epidemic among injecting drug users. Infect Genet Evol 5: 131-139.
9. Thomson BJ, Finch RG (2005) Hepatitis C virus infection. Clin Microbiol Infect 11: 86-94.
10. Jimenez-Hernandez N, Torres-Puente M, Bracho MA, Garcia-Robles I, Ortega E, et al. (2007) Epidemic dynamics of two coexisting hepatitis C virus subtypes. J Gen Virol 88: 123-133.
11. Lauer GM, Walker BD (2001) Hepatitis C virus infection. N Engl J Med 345: 41-52.
12. Centro Nacional de Epidemiología (2006) Vigilancia epidemioloígica del SIDA en España. Registro Nacional de casos de SIDA Informe Semestral no 2: Accessible at http://cne.iscii.es.
13. Okamoto H, Kurai K, Okada SI, Yamamoto K, Iizuka H, et al. (1992) Full-length sequence of hepatitis C virus genome having poor homology to reported isolates: Comparative study of four distinct genotypes. J Gen Virol 188: 331-341.
14. Smith DB, Pathirana S, Davidson F, Lawlor E, Power J, et al. (1997) The origin of hepatitis C virus genotypes. J Gen Virol 78: 321-328.
15. Zein NN (2000) Clinical significance of hepatitis C virus genotypes. Clin Microbiol Rev 13: 223-235.
16. Farci P, Shimoda A, Coiana A, Diaz G, Peddis G, et al. (2000) The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science 288: 339-344.
17. Farci P, Purcell RH (2000) Clinical significance of hepatitis C virus genotypes and quasispecies. Semin Liver Dis 20: 103-126.
18. Peeters M, Courgnaud V, Abela B (2001) Genetic Diversity of Lentiviruses in Non-Human Primates. AIDS Rev 3: 3-10.
19. Yun Z, Lara C, Johansson B, Lorenzana dR I, Sonnerborg A (1996) Discrepancy of hepatitis C virus genotypes as determined by phylogenetic analysis of partial NS5 and core sequences. J Med Virol 49: 155-160.
20. Simmonds P, Alberti A, Alter HJ, Bonino F, Bradley DW, et al. (1994) A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 19: 1321-1324.
21. Viazov S, Widell A, Nordenfelt E (2000) Mixed infection with two types of hepatitis C virus is probably a rare event. Infection 28: 21-25.
22. Kalinina O, Norder H, Mukomolov S, Magnius LO (2002) A natural intergenotypic recombinant of hepatitis C virus identified in St. Petersburg. J Virol 76: 4034-4043.
23. Kalinina O, Norder H, Magnius LO (2004) Full-length open reading frame of a recombinant hepatitis C virus strain from St Petersburg: proposed mechanism for its formation. J Gen Virol 85: 1853-1857.
24. Colina R, Casane D, Vasquez S, Garcia-Aguirre L, Chunga A, et al. (2004) Evidence of intratypic recombination in natural populations of hepatitis C virus. J Gen Virol 85: 31-37.
25. Kageyama S, Agdamag DM, Alesna ET, Leano PS, Heredia AM, et al. (2006) A natural inter-genotypic (2b/1b) recombinant of hepatitis C virus in the Philippines. J Med Virol 78: 1423-1428.
26. Legrand-Abravanel F, Claudinon J, Nicot F, Dubois M, Chapuy-Regaud S, et al. (2007) A new natural intergenotypic (2/5) recombinant of Hepatitis C virus. J Virol 81: 4357-4362.
27. Moreno MP, Casane D, Lopez L, Cristina J (2006) Evidence of recombination in quasispecies populations of an Hepatitis C Virus patient undergoing antiviral therapy. Virol J 3: 87.
28. Worobey M, Holmes EC (1999) Evolutionary aspects of recombination in RNA viruses. J Gen Virol 80: 2535-2543.
29. Moya A, Holmes EC, Gonzaález-Candelas F (2004) The population genetics and evolutionary epidemiology of RNA viruses. Nat Rev Micro 2: 279-288.
30. Becher P, Orlich M, Thiel HJ (2001) RNA recombination between persisting pestivirus and a vaccine strain: generation of cytopathogenic virus and induction of lethal disease. J Virol 75: 6256-6264.
31. Worobey M, Rambaut A, Holmes EC (1999) Widespread intra-serotype recombination in natural populations of dengue virus. Proceedings of the National Academy of Sciences U S A 96: 7352-7357.
32. Worobey M, Holmes EC (2001) Homologous recombination in GB Virus C/ Hepatitis G Virus. Mol Biol Evol 18: 254-261.
33. Twiddy SS, Holmes EC (2003) The extent of homologous recombination in members of the genus Flavivirus. J Gen Virol 84: 429-440.
34. Noppornpanth S, Lien TX, Poovorawan Y, Smits SL, Osterhaus ADME, et al. (2006) Identification of a naturally occurring recombinant genotype 2/6 hepatitis C virus. J Virol 80: 7569-7577.
35. Moreau I, Hegarty S, Levis J, Sheehy P, Crosbie O, et al. (2006) Serendipitous identification of natural Intergenotypic recombinants of hepatitis C in Ireland. Virol J 3: 95.
36. Bernardin F, Herring B, Page-Shafer K, Kuiken C, Delwart E (2006) Absence of HCV viral recombination following superinfection. J Viral Hep 13: 532-537.
37. Judo MS, Wedel AB, Wilson C (1998) Stimulation and suppression of PCR-mediated recombination. Nuc Acids Res 26: 1819-1825.
38. Shafikhani S (2002) Factors affecting PCR-mediated recombination. Environ Microbiol 4: 482-486.
39. Accapezzato D, Fravolini F, Casciaro MA, Paroli M (2002) Hepatitis C flare due to superinfection by genotype 4 in an HCV genotype 1b chronic carrier. Eur J Gastroenterol Hepatol 14: 879-881.
40. Blackard JT, Sherman KE (2007) Hepatitis C virus coinfection and superinfection. J Infect Dis 195: 519-524.
41. Herring BL, Page-Shafer K, Tobler LH, Delwart EL (2004) Frequent hepatitis C virus superinfection in injection drug users. J Infect Dis 190: 1396-1403.
42. Forton DM, Karayiannis P, Mahmud N, Taylor-Robinson SD, Thomas HC (2004) Identification of unique hepatitis C virus quasispecies in the central nervous system and comparative analysis of internal translational efficiency of brain, liver, and serum variants. J Virol 78: 5170-5183.
43. Dahari H, Feliu A, Garcia-Retortillo M, Forns X, Neumann AU (2005) Second hepatitis C replication compartment indicated by viral dynamics during liver transplantation. J Hepatol 42: 491-498.
44. Roque-Afonso AM, Ducoulombier D, Di Liberto G, Kara R, Gigou M, et al. (2005) Compartmentalization of hepatitis C virus genotypes between plasma and peripheral blood mononuclear cells. J Virol 79: 6349-6357.
45. Di Liberto G, Roque-Afonso AM, Kara R, Ducoulombier D, Fallot G, et al. (2006) Clinical and therapeutic implications of hepatitis C virus compartmentalization. Gastroenterology 131: 76-84.
46. Minosse C, Calcaterra S, Abbate I, Selleri M, Zaniratti MS, et al. (2006) Possible compartmentalization of hepatitis C viral replication in the genital tract of HIV-1-coinfected women. J Infect Dis 194: 1529-1536.
47. Blackard JT, Hiasa Y, Smeaton L, Jamieson DJ, Rodriguez I, et al. (2007) Compartmentalization of hepatitis C virus (HCV) during HCV/HIV coinfection. J Infect Dis 195: 1765-1773.
48. Schaller T, Appel N, Koutsoudakis G, Kallis S, Lohmann V, et al. (2007) Analysis of hepatitis C virus superinfection exclusion by using novel fluorochrome gene-tagged viral genomes. J Virol 81: 4591-4603.
49. Tscherne DM, Evans MJ, von Hahn T, Jones CT, Stamataki Z, et al. (2007) Superinfection exclusion in cells infected with hepatitis C virus. J Virol 81: 3693-3703.
50. Okada S, Akahane Y, Suzuki H, Okamoto H, Mishiro S (1992) The degree of variability in the amino terminal region of the E2/NS1 protein of hepatitis C virus correlates with responsiveness to interferon therapy in viremic patients. Hepatology 16: 619-624.
51. Koizumi K, Enomoto N, Kurosaki M, Murakami T, Izumi N, et al. (1995) Diversity of quasispecies in various disease stages of chronic hepatitis C virus infection and its significance in interferon treatment. Hepatology 22: 30-35.
52. Le Guen B, Squadrito G, Nalpas B, Berthelot P, Pol S, et al. (1997) Hepatitis C virus genome complexity correlates with response to interferon therapy: a study in French patients with chronic hepatitis C. Hepatology 25: 1250-1254.
53. Polyak SJ, Faulkner G, Carithers RL, Corey L, Gretch DR (1997) Assessment of hepatitis C virus quasispecies heterogeneity by gel shift analysis: correlation with response to interferon therapy. J Infect Dis 175: 1101-1107.
54. Chambers TJ, Fan X, Droll DA, Hembrador E, Slater T, et al. (2005) Quasispecies heterogeneity within the E1/E2 region as a pretreatment variable during pegylated interferon therapy of chronic hepatitis C virus infection. J Virol 79: 3071-3083.
55. Donlin MJ, Cannon NA, Yao E, Li J, Wahed A, et al. (2007) Pretreatment sequence diversity differences in the full-length Hepatitis C Virus open reading frame correlate with early response to therapy. J Virol 81: 8211-8224.
56. Weiner AJ, Geysen HM, Christopherson C, Hall JE, Mason TJ, et al. (1992) Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. Proc Natl Acad Sci U S A 89: 3468-3472.
57. Kato N, Sekiya H, Ootsuyama Y, Nakazawa T, Hijikata M, et al. (1993) Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus. J Virol 67: 3923-3930.
58. Taniguchi S, Okamoto H, Sakamoto M, Kojima M, Tsuda F, et al. (1993) A structurally flexible and antigenically variable N-terminal domain of the hepatitis C virus E2/NS1 protein: implication for an escape from antibody. Virology 195: 297-301.
59. Fleury HJ, Toni T, Lan NT, Hung PV, Deshpande A, et al. (2006) Susceptibility to antiretroviral drugs of CRF01Æ, CRF02_AG, and subtype C viruses from untreated patients of Africa and Asia: comparative genotypic and phenotypic data. AIDS Res Hum Retroviruses 22: 357-366.
60. Carvajal-Rodriguez A, Crandall KA, Posada D (2007) Recombination favors the evolution of drug resistance in HIV-1 during antiretroviral therapy. Infect Genet Evol 7: 476-483.
61. Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, et al. (1995) Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region. J Clin Invest 96: 224-230.
62. Squadrito G, Leone F, Sartori M, Nalpas B, Berthelot P, et al. (1997) Mutations in the nonstructural 5A region of hepatitis C virus and response of chronic hepatitis C to interferon alfa. Gastroenterology 113: 567-572.
63. Saiz JC, Lopez-Labrador FX, Ampurdanes S, Dopazo J, Forns X, et al. (1998) The prognostic relevance of the nonstructural 5A gene interferon sensitivity determining region is different in infections with genotype 1b and 3a isolates of hepatitis C virus. J Infect Dis 177: 839-847.
64. Chayama K, Tsubota A, Kobayashi M, Okamoto K, Hashimoto M, et al. (1997) Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity-determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection. Hepatology 25: 745-749.
65. Watanabe H, Enomoto N, Nagayama K, Izumi N, Marumo F, et al. (2001) Number and position of mutations in the interferon (IFN) sensitivity-determining region of the gene for nonstructural protein 5A correlate with IFN efficacy in hepatitis C virus genotype 1b infection. J Infect Dis 183: 1195-1203.
66. Murayama M, Katano Y, Nakano I, Ishigami M, Hayashi K, et al. (2007) A mutation in the interferon sensitivity-determining region is associated with responsiveness to interferon-ribavirin combination therapy in chronic hepatitis patients infected with a Japan-specific subtype of hepatitis C virus genotype 1B. J Med Virol 79: 35-40.
67. Hofgartner WT, Polyak SJ, Sullivan DG, Carithers RL Jr, Gretch DR (1997) Mutations in the NS5A gene of hepatitis C virus in North American patients infected with HCV genotype 1a or 1b. J Med Virol 53: 118-126.
68. Khorsi H, Castelain S, Wyseur A, Izopet J, Canva V, et al. (1997) Mutations of hepatitis C virus 1b NS5A 2209-2248 amino acid sequence do not predict the response to recombinant interferon-alfa therapy in French patients. J Hepatol 27: 72-77.
69. Zeuzem S, Lee JH, Roth WK (1997) Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alfa. Hepatology 25: 740-744.
70. Duverlie G, Khorsi H, Castelain S, Jaillon O, Izopet J, et al. (1998) Sequence analysis of the NS5A protein of European hepatitis C virus 1b isolates and relation to interferon sensitivity. J Gen Virol 79: 1373-1381.
71. Rispeter K, Lu M, Zibert A, Wiese M, de Oliveira JM, et al. (1998) The "interferon sensitivity determining region" of hepatitis C virus is a stable sequence element. J Hepatol 29: 352-361.
72. Chung RT, Monto A, Dienstag JL, Kaplan LM (1999) Mutations in the NS5A region do not predict interferon-responsiveness in american patients infected with genotype 1b hepatitis C virus. J Med Virol 58: 353-358.
73. Ibarrola N, Moreno-Monteagudo JA, Saiz M, Garcia-Monzon C, Sobrino F, et al. (1999) Response to retreatment with interferon-alpha plus ribavirin in chronic hepatitis C patients is independent of the NS5A gene nucleotide sequence. Am J Gastroenterol 94: 2487-2495.
74. Squadrito G, Orlando ME, Cacciola I, Rumi MG, Artini M, et al. (1999) Long-term response to interferon alpha is unrelated to "interferon sensitivity determining region" variability in patients with chronic hepatitis C virus-1b infection. J Hepatol 30: 1023-1027.
75. Witherell GW, Beineke P (2001) Statistical analysis of combined substitutions in nonstructural 5A region of hepatitis C virus and interferon response. J Med Virol 63: 8-16.
76. Pascu M, Martus P, Hohne M, Wiedenmann B, Hopf U, et al. (2004) Sustained virological response in hepatitis C virus type 1b infected patients is predicted by the number of mutations within the NS5A-ISDR: a meta-analysis focused on geographical differences. Gut 53: 1345-1351.
77. Schinkel J, Spaan WJM, Kroes ACM (2001) Mutations in the NS5A gene and hepatitis C virus resistance to interferon therapy: an end to the controversy. 8th International Symposium of Hepatitis C Virus and Related Viruses. P-266.
78. Torres-Puente M, Cuevas JM, Jiménez N, Bracho MA, García-Robles I, et al. (2007) Contribution of insertions and deletions to the variability of hepatitis C virus populations. J Gen Virol 88: 2198-2203.
79. Torres-Puente M, Cuevas JM, Jiménez N, Bracho MA, García-Robles I, et al. (2008) Genetic variability in hepatitis C virus and its role in antiviral treatment response. J Viral Hep 15: 188-199.
80. Kuiken C, Combet C, Bukh J, Shin-i T, Deleage G, Mizokami M, et al. (2006) A comprehensive system for consistent numbering of HCV sequences, proteins and epitopes. Hepatology 44: 1355-1361.
81. Penin F, Combet C, Germanidis G, Frainais PO, Deleage G, et al. (2001) Conservation of the conformation and positive charges of hepatitis C virus E2 envelope glycoprotein hypervariable region 1 points to a role in cell attachment. J Virol 75: 5703-5710.
82. Yagnik AT, Lahm A, Meola A, Roccasecca RM, Ercole BB, et al. (2000) A model for the hepatitis C virus envelope glycoprotein E2. Proteins 40: 355-366.
83. Troesch M, Meunier I, Lapierre P, Lapointe N, Alvarez F, et al. (2006) Study of a novel hypervariable region in hepatitis C virus (HCV) E2 envelope glycoprotein. Virology 352: 357-367.
84. Durante ME, Forton DM, Ruggiero G, Karayiannis P (2003) Hepatitis C virus E2 and NS5A region variability during sequential treatment with two interferon-alpha preparations. J Med Virol 70: 62-73.
85. Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, et al. (1996) Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. New Engl J Med 334: 77-81.
86. Gale MJ, Korth MJ, Tang NM, Tan SL, Hopkins DA, et al. (1997) Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. Virology 230: 217-227.
87. Gale M Jr, Katze MG (1998) Molecular mechanisms of interferon resistance mediated by viral-directed inhibition of PKR, the interferon-induced protein kinase. Pharmacol Ther 78: 29-46.
88. Bracho MA, García-Robles I, Jiménez N, Torres-Puente M, Moya A, et al. (2004) Effect of oligonucleotide primers in determining viral variability within hosts. Virol J 1. pp 13.
89. Staden R, Beal K, Bonfield J (1999) The Staden package, 1998. In: Misener S, Krawetz S, eds. Computer Methods in Molecular Biology. Totowa: The Humana Press Inc. pp 115-130.
90. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG (1997) The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucl Acids Res 25: 4876-4882.
91. Posada D, Crandall KA (1998) Modeltest: testing the model of DNA substitution. Bioinformatics 14: 917-918.
92. Swofford DL (2002) PAUP*. Phylogenetic Analysis Using Parsimony (* and Other Methods), version 4.0beta [computer program]. Sunderland, MA: Sinauer Associates.
93. Akaike H (1974) A new look at the statistical model identification. IEEE Trans Autom Control 19: 716-723.
94. Guindon S, Gascuel O (2003) A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst Biol 52: 696-704.
95. Martin DP, Williamson C, Posada D (2005) RDP2: recombination detection and analysis from sequence alignments. Bioinformatics 21: 260-262.
96. Martin D, Rybicki E (2000) RDP: detection of recombination amongst aligned sequences. Bioinformatics 16: 562-563.
97. Salminen MO, Carr JK, Burke DS, McCutchan FE (1995) Identification of breakpoints in intergenotypic recombinants of HIV type 1 by bootscanning. AIDS Res Hum Retroviruses 11: 1423-1425.
98. Smith JM (1992) Analyzing the mosaic structure of genes. J Mol Evol 34: 126-129.
99. Padidam M, Sawyer S, Fauquet CM (1999) Possible emergence of new geminiviruses by frequent recombination. Virology 265: 218-225.
100. Gibbs MJ, Armstrong JS, Gibbs AJ (2000) Sister-scanning: a Monte Carlo procedure for assessing signals in recombinant sequences. Bioinformatics 16: 573-582.
101. Schmidt HA, Strimmer K, Vingron M, von Haeseler A (2002) TREE-PUZZLE: maximum likelihood phylogenetic analysis using quartets and parallel computing. Bioinformatics 18: 502-504.
102. Shimodaira H, Hasegawa M (1999) Multiple comparisons of log-likelihoods with applications to phylogenetic inference. Mol Biol Evol 16: 1114-1116.
103. Strimmer K, Rambaut A (2002) Inferring confidence sets of possibly misspecified gene trees. Proc R Soc Lond Ser B 269: 137-142.